India's 1st dedicated medtech fund gets SEBI nod
MedArtha Capital just became India's first dedicated medtech fund after getting SEBI approval.
It is aiming to raise ₹1,000 crore (with up to half coming from a government innovation scheme) to help grow the country's medical technology sector.
Investing in local manufacturing
Over the next two-to-three years (i.e., through 2028-2029), MedArtha plans to invest in 10-12 companies making things like MRI machines, CT scanners, and other high-tech devices we mostly import today.
The idea is to ramp up local manufacturing and support Make in India so more of these essential tools are built right here.
Backing contract development and manufacturing
The eight-year fund also wants to set up contract development and manufacturing facilities, something India's medtech scene really needs.
By backing these capabilities, MedArtha hopes to help homegrown companies scale up and rely less on imports for critical healthcare tech.